A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinib

• Amir Hossein Daneshmanesh,

  Roles Data curation, Formal analysis, Methodology, Validation, Writing – original draft, Writing – review & editing

  Affiliations Department of Oncology-Pathology, Immune and Gene therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna, Stockholm, Sweden, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Mohammad Hojjat-Farsangi,

  Roles Methodology, Writing – review & editing

  Affiliations Department of Oncology-Pathology, Immune and Gene therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna, Stockholm, Sweden, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Amineh Ghaderi,

  Roles Methodology, Writing – review & editing

  Affiliations Department of Oncology-Pathology, Immune and Gene therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna, Stockholm, Sweden, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Ali Moshfegh,

  Roles Writing – review & editing

  Affiliations Department of Oncology-Pathology, Immune and Gene therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna, Stockholm, Sweden, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Lotta Hansson,

  Roles Funding acquisition, Writing – review & editing

  Affiliations Department of Oncology-Pathology, Immune and Gene therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna, Stockholm, Sweden, Karolinska Institutet, Stockholm, Sweden, Department of Hematology, Karolinska University Hospital Solna, Stockholm, Sweden

  ⨯
• Johan Schultz,

  Roles Writing – review & editing

  Affiliation Kancera AB, Karolinska Institutet Science Park, Stockholm, Sweden

  ⨯
• Jan Vågberg,

  Roles Writing – review & editing

  Affiliation Kancera AB, Karolinska Institutet Science Park, Stockholm, Sweden

  ⨯
• Styrbjörn Byström,

  Roles Writing – review & editing

  Affiliation Kancera AB, Karolinska Institutet Science Park, Stockholm, Sweden

  ⨯
• Elisabeth Olsson,

  Roles Writing – review & editing

  Affiliation Kancera AB, Karolinska Institutet Science Park, Stockholm, Sweden

  ⨯
• Thomas Olin,

  Roles Writing – review & editing

  Affiliation Kancera AB, Karolinska Institutet Science Park, Stockholm, Sweden

  ⨯
• Anders Österborg,

  Roles Conceptualization, Funding acquisition, Project administration, Resources, Supervision, Writing – original draft, Writing – review & editing

  Affiliations Department of Oncology-Pathology, Immune and Gene therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna, Stockholm, Sweden, Karolinska Institutet, Stockholm, Sweden, Department of Hematology, Karolinska University Hospital Solna, Stockholm, Sweden

  ⨯
• Håkan Mellstedt

  Roles Conceptualization, Formal analysis, Funding acquisition, Methodology, Project administration, Resources, Supervision, Writing – original draft, Writing – review & editing

  * E-mail: hakan.mellstedt@sll.se

  Affiliations Department of Oncology-Pathology, Immune and Gene therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna, Stockholm, Sweden, Karolinska Institutet, Stockholm, Sweden, Department of Hematology, Karolinska University Hospital Solna, Stockholm, Sweden

  http://orcid.org/0000-0001-6756-0609

  ⨯